Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: Effect of the −174 G/C IL-6 gene polymorphism - 26/08/11
, Antonio Gayá, MD, PhD b, Ignacio Segura, MD a, Javier Calvo, MD, PhD b, Cristina Imízcoz, RN a, Alejandro Berenguel, MD a, Eduardo Alegría, MD, PhD cRiassunto |
C-reactive protein (CRP), interleukin-6 (IL-6), and the −174 GC IL-6 gene polymorphism were analyzed after coronary angioplasty in 50 patients, 25 of whom were treated with the glycoprotein IIb/IIIa platelet receptor inhibitor eptifibatide for 24 hours. It was found that glycoprotein IIb/IIIa inhibition significantly blocked postangioplasty CRP increases in all patients but blocked IL-6 increases only in patients carrying the −174 GG genotype.
Il testo completo di questo articolo è disponibile in PDF.| This work was supported by a research grant from the Spanish Society of Cardiology, Madrid, Spain. |
Vol 94 - N° 10
P. 1300-1303 - novembre 2004 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
